Skip to content

The incidence of chronic pain in ropivacaine combined with dexmedetomidine for incision infiltration after laparoscopic cholecystectomy

The incidence of chronic pain in ropivacaine combined with dexmedetomidine for incision infiltration after laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17011158
Enrollment
Unknown
Registered
2017-04-16
Start date
2017-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Cholecystectomy

Interventions

Group RD:Ropivacaine combined with Dexmedetomidine

Sponsors

The First People's Hospital of Hefei, Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who were scheduled for elective laparoscopic cholecystectomy under general anesthesia because of gall bladder polyps, chronic cholecystitis or gallstones were enrolled in this study.

Exclusion criteria

Exclusion criteria: Patients with a BMI 30 kg/m2, heart rate (HR) <50 bpm at a pre-operativevisit, acute cholecystitis, chronic pain diseases except gallstone disease, renal or hepatic disease, analgesics or tranquilizers usage (during the last month before the cholecystectomy), a history of alcohol or drug abuse, ASA physical status III or greater, contraindications to any of the drugs used in the study, and pregnancy. Moreover, patients were excluded if the operation was converted to an open procedure, a drainage catheter was inserted

Design outcomes

Primary

MeasureTime frame
The requirement for analgesics, nausea and vomiting, condition of the wound healing were all recorded within 48 h after operation;the incidence of chronic pain after laparoscopic cholecystectomy;

Countries

China

Contacts

Public ContactYu Junma

The First People's Hospital of Hefei, Anhui Medical University

majuny163@163.com+86 15505510801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026